1. Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010 
M. Colafigli, C. Torti, E.M. Trecarichi, L. Albini, A. Rosi, V. Micheli, N. Manca, G. Penco, B. Bruzzone, G. Punzi, P. Corsi, G. Parruti, P. Bagnarelli, L. Monno, A. Gonnelli, R. Cauda, S. Di Giambenedetto 
Clinical Microbiology and Infection 
Volume 18, Issue 8, Pages E299-E304 (August 2012)
DOI: /j x
Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

2. FIG. 1
Evolution of resistance (at least one major IAS mutation) by calendar year from 2000 to 2010 in naive patients with non-acute/non-recent infection (a, n = 2937), evolution of the prevalence of B, non-B and unknown subtypes (b) and evolution of the prevalence of drug resistance in B subtype (c) and in non-B subtypes (d). NRTI, nucleoside reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, protease inhibitor.
Clinical Microbiology and Infection  , E299-E304DOI: ( /j x)
Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions